The United States Anti-Doping Agency (USADA) announced Friday that it has imposed a one-year ban on 80-year-old track cyclist Barbara Gickel after she tested positive for methyltestosterone.

According to USADA, Gickel requested a doping control to validate the age-group world record she set on August 29, 2019 (the women's 75-79 age-group 500m time trial mark, which Gickel tentatively set at 44.062).

Zickel admitted that she had been using drugs containing methyltestosterone since March 2005, so her results, along with all results since August 29, 2015, were invalidated. She applied for a retroactive Therapeutic Use Exemption (TUE), but USADA denied her request.

According to USADA, Zickel did not declare the drug on any of her previous doping control forms, and "the documentation she submitted did not demonstrate that she had a medical condition requiring the use of methyltestosterone and that the use of the drug was not likely to result in a return to normal health or more She denied the TUE "because it was not shown that it was likely to result in further athletic performance benefits.

Zickel's urine collected at the 2019 USA Cycling Masters Track National Championships contained methyltestosterone metabolites, which are non-specific substances classified as anabolics, a broad anti doping rules, and is banned at all times.

The California native has lost her individual pursuit, sprint, and time trial titles, including the 200m flying start time trial and the 2km individual pursuit age group record.

She attempted to contest the disqualification of her results and an independent arbitrator concluded that her results should have been disqualified from the first day she learned that her medication contained a prohibited substance.